Franklin Biotechnology Discovery Fund Quote
| FBDIX Fund | USD 141.32 0.46 0.32% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Franklin Biotechnology is trading at 141.32 as of the 2nd of December 2024; that is 0.32% down since the beginning of the trading day. The fund's open price was 141.78. Franklin Biotechnology has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Franklin Biotechnology Discovery are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Under normal market conditions, the fund invests at least 80 percent of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20 percent of its net assets in equity or debt securities of any type of issuer. More on Franklin Biotechnology Discovery
Moving against Franklin Mutual Fund
Franklin Mutual Fund Highlights
| Fund Concentration | Franklin Templeton Investments Funds, Large Funds, Health Funds, Health, Franklin Templeton Investments, Large, Health (View all Sectors) |
| Update Date | 31st of December 2024 |
| Expense Ratio Date | 1st of September 2022 |
| Fiscal Year End | April |
Franklin Biotechnology Discovery [FBDIX] is traded in USA and was established 2nd of December 2024. Franklin Biotechnology is listed under Franklin Templeton Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Franklin Templeton Investments family. This fund currently has accumulated 804.12 M in assets under management (AUM) with no minimum investment requirementsFranklin Biotechnology is currently producing year-to-date (YTD) return of 11.22%, while the total return for the last 3 years was 4.89%.
Check Franklin Biotechnology Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Franklin Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Franklin Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Franklin Biotechnology Discovery Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Franklin Biotechnology Discovery Mutual Fund Constituents
| CLVS | Clovis Oncology | Stock | Health Care | |
| INCY | Incyte | Stock | Health Care | |
| NBIX | Neurocrine Biosciences | Stock | Health Care | |
| BMRN | Biomarin Pharmaceutical | Stock | Health Care | |
| VRTX | Vertex Pharmaceuticals | Stock | Health Care | |
| SGEN | Seagen Inc | Stock | Health Care | |
| RETA | Reata Pharmaceuticals | Stock | Health Care | |
| REGN | Regeneron Pharmaceuticals | Stock | Health Care |
Franklin Biotechnology Risk Profiles
| Mean Deviation | 0.8891 | |||
| Standard Deviation | 1.21 | |||
| Variance | 1.46 | |||
| Risk Adjusted Performance | (0.05) |
Franklin Biotechnology Against Markets
Other Information on Investing in Franklin Mutual Fund
Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |